5/16/2022 6:35:34 AM
BIOLASE Regains Compliance With Nasdaq Minimum Bid Price Requirement
5/9/2022 6:52:15 AM
BIOLASE Names Kenneth Yale To Board
1/18/2022 8:38:57 AM
BIOLASE Collaborates With BMW Performance Center West And Winner Of BMW Sweepstakes
1/10/2022 6:36:20 AM
BIOLASE Sees Q4 Revenue To Be In Range Of $12.2 Mln To $12.5 Mln
1/6/2022 9:03:35 AM
BIOLASE Announces FDA 510(k) Clearance Of EdgePRO Laser-Assisted Microfluidic Irrigation Device For Endodontists
8/31/2021 9:13:40 AM
BIOLASE Announces Clinical Advisory Partnership With Endodontist Stephen Buchanan
6/3/2021 9:43:29 AM
Recent Studies Show BIOLASE's Waterlase Laser Technology Beneficial For Treatment Of Peri-Implantitis
3/25/2021 4:08:14 PM
BIOLASE Q4 Loss Per Share Of $0.07 Vs. $0.13 Last Year
2/23/2021 7:39:59 AM
BIOLASE Promotes John Beaver To President And CEO
2/1/2021 5:51:29 AM
BIOLASE Urges Stockholders To Vote Today "FOR" The Reverse Stock Split
1/26/2021 9:00:40 AM
BIOLASE Expects Q4 Total Revenue Of $8.2 Mln-$8.5 Mln